Treatment outcomes in multidrug resistant tuberculosis-human immunodeficiency virus Co-infected patients on anti-retroviral therapy at Sizwe Tropical Disease Hospital Johannesburg, South Africa

BACKGROUND: Multidrug resistant-tuberculosis (MDR-TB) is a threat to global tuberculosis control which is worsened by human immune-deficiency virus (HIV) co-infection. There is however paucity of data on the effects of antiretroviral treatment (ART) before or after starting MDR-TB treatment. This st...

Descripción completa

Detalles Bibliográficos
Autores principales: Umanah, Teye, Ncayiyana, Jabulani, Padanilam, Xavier, Nyasulu, Peter S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625623/
https://www.ncbi.nlm.nih.gov/pubmed/26511616
http://dx.doi.org/10.1186/s12879-015-1214-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625623/
https://www.ncbi.nlm.nih.gov/pubmed/26511616
http://dx.doi.org/10.1186/s12879-015-1214-3

Ejemplares similares